ArticleJournal of inflammation (London, England)2026

Montelukast suppresses NLRP3 inflammasome activation as a potential prophylactic agent against gout arthritis flares.

Daniel C Shippy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.